Changes in perfusion of mouse tumours after photodynamic therapy
- PMID: 8314306
- DOI: 10.1002/ijc.2910560214
Changes in perfusion of mouse tumours after photodynamic therapy
Abstract
The influence of photodynamic therapy (PDT) on vascular perfusion was investigated in 2 s.c. mouse tumours, a radiation-induced fibrosarcoma (RIF I) and a squamous-cell carcinoma (SCCVII). The 86Rb extraction technique was used to measure changes in perfusion relative to cardiac output at various intervals after interstitial PDT. Control groups showed that vascular perfusion in the RIF I tumours decreased with increasing tumour size. For both tumours, of constant size, vascular perfusion decreased to less than 10% of control values within 5 min after high PDT doses. Significant decreases in vascular perfusion were also seen after lower, sub-curative doses. Thereafter there was slow recovery towards control levels. Photofrin given at shorter intervals before illumination generally resulted in even larger decreases in tumour perfusion, and slower recovery. Comparison of tumour perfusion measurements after PDT with tumour response revealed an inverse correlation with tumour growth delay both for the RIF I and for the SCCVII tumours. PDT with sub-curative light doses appears to decrease vascular perfusion in the RIF I and SCCVII for a period of at least 24 hr. The most severe reductions in tumour blood flow were associated with the longest regrowth delays, indicating a major role of vascular damage in tumour response to PDT.
Similar articles
-
Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.Cancer Res. 2003 Nov 15;63(22):7584-90. Cancer Res. 2003. PMID: 14633671
-
Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.Br J Cancer. 1995 Aug;72(2):344-50. doi: 10.1038/bjc.1995.336. Br J Cancer. 1995. PMID: 7640216 Free PMC article.
-
Cellular levels of photosensitisers in tumours: the role of proximity to the blood supply.Br J Cancer. 1994 Oct;70(4):604-10. doi: 10.1038/bjc.1994.358. Br J Cancer. 1994. PMID: 7917904 Free PMC article.
-
Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy.Br J Cancer. 1996 Feb;73(3):288-93. doi: 10.1038/bjc.1996.51. Br J Cancer. 1996. PMID: 8562332 Free PMC article.
-
The effect of therapy on tumour vascular function.Int J Radiat Biol. 1991 Jul-Aug;60(1-2):311-25. doi: 10.1080/09553009114552071. Int J Radiat Biol. 1991. PMID: 1677988 Review.
Cited by
-
Implicit and explicit dosimetry in photodynamic therapy: a New paradigm.Lasers Med Sci. 1997 Oct;12(3):182-99. doi: 10.1007/BF02765099. Lasers Med Sci. 1997. PMID: 20803326
-
Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours.Br J Cancer. 2003 Mar 10;88(5):760-6. doi: 10.1038/sj.bjc.6600792. Br J Cancer. 2003. PMID: 12618887 Free PMC article.
-
Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy.Br J Cancer. 2000 Jun;82(11):1835-43. doi: 10.1054/bjoc.2000.1157. Br J Cancer. 2000. PMID: 10839299 Free PMC article.
-
Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate.Br J Cancer. 1998 May;77(9):1386-94. doi: 10.1038/bjc.1998.231. Br J Cancer. 1998. PMID: 9652753 Free PMC article.
-
Aminolevulinic acid-photodynamic therapy combined with topically applied vascular disrupting agent vadimezan leads to enhanced antitumor responses.Photochem Photobiol. 2011 Jul-Aug;87(4):910-9. doi: 10.1111/j.1751-1097.2011.00943.x. Epub 2011 Jun 13. Photochem Photobiol. 2011. PMID: 21575001 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources